Paul Tudor Jones Crispr Therapeutics Ag Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 47,100 shares of CRSP stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,100

Previous 51,242 8.08%

Holding current value

$3.41 Million

Previous $1.74 Million 31.38%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$34.03 - $53.02 $1.12 Million - $1.74 Million	32,905 Added 179.45%	51,242 $1.74 Million
Q4 2024 Feb 14, 2025	SELL	$38.65 - $55.15 $1.11 Million - $1.58 Million	-28,662 Reduced 60.98%	18,337 $721,000
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $2.1 Million - $2.95 Million	46,999 New	46,999 $2.21 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $348,306 - $511,637	5,741 Added 35.77%	21,790 $1.49 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $619,812 - $1.16 Million	16,049 New	16,049 $1 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $1.11 Million - $1.73 Million	25,562 New	25,562 $1.44 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $41,384 - $69,347	1,056 Added 4.42%	24,949 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $257,292 - $352,797	4,211 Added 21.4%	23,893 $1.56 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $229,162 - $391,372	-5,301 Reduced 21.22%	19,682 $1.2 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $212 - $316	-4 Reduced 0.02%	24,983 $1.57 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $259,403 - $411,884	3,701 Added 17.39%	24,987 $1.89 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $2.35 Million - $3.33 Million	21,286 New	21,286 $2.38 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $1.75 Million - $3.33 Million	-15,841 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $705,716 - $1.53 Million	8,858 Added 126.85%	15,841 $2.43 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $150,406 - $192,826	1,916 Added 37.81%	6,983 $584,000
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $238,007 - $470,141	-6,182 Reduced 54.96%	5,067 $372,000
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $184,701 - $342,914	-5,484 Reduced 32.77%	11,249 $477,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $613,766 - $1.22 Million	16,733 New	16,733 $1.02 Million
Q2 2018 Aug 14, 2018	SELL	$42.62 - $73.59 $366,872 - $633,462	-8,608 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $202,460 - $500,727	8,608 New	8,608 $393,000

Others Institutions Holding CRSP

# of Institutions

540

Shares Held

68.7M

Call Options Held

3.67M

Put Options Held

2.25M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $5.64B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account